CCND3 and non-small cell lung carcinoma: Some reports have revealed that miR‐138 could target PDK1,21 CCND3,41 and the enhancer of zeste homolog 2.42 Our results demonstrate that miR‐138 and miR‐195 target survivin in NSCLC and enhance the tumor suppressive effect of YM‐155.